[go: up one dir, main page]

ZA201801394B - Fusion protein - Google Patents

Fusion protein

Info

Publication number
ZA201801394B
ZA201801394B ZA2018/01394A ZA201801394A ZA201801394B ZA 201801394 B ZA201801394 B ZA 201801394B ZA 2018/01394 A ZA2018/01394 A ZA 2018/01394A ZA 201801394 A ZA201801394 A ZA 201801394A ZA 201801394 B ZA201801394 B ZA 201801394B
Authority
ZA
South Africa
Prior art keywords
fusion protein
fusion
protein
Prior art date
Application number
ZA2018/01394A
Other languages
English (en)
Inventor
Rudolf Valenta
Carolin Cornelius
Original Assignee
Viravaxx AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viravaxx AG filed Critical Viravaxx AG
Publication of ZA201801394B publication Critical patent/ZA201801394B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • A61K39/292Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2018/01394A 2015-09-05 2018-02-28 Fusion protein ZA201801394B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15183983.4A EP3138579A1 (fr) 2015-09-05 2015-09-05 Protéine de fusion pour son utilisation dans le traitement d'une infection par le virus de l'hépatite b
PCT/EP2016/070824 WO2017037280A1 (fr) 2015-09-05 2016-09-05 Protéine de fusion

Publications (1)

Publication Number Publication Date
ZA201801394B true ZA201801394B (en) 2020-07-29

Family

ID=54072694

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2018/01394A ZA201801394B (en) 2015-09-05 2018-02-28 Fusion protein

Country Status (15)

Country Link
US (2) US20180244726A1 (fr)
EP (2) EP3138579A1 (fr)
JP (1) JP6830955B2 (fr)
KR (1) KR20180039739A (fr)
CN (1) CN108472356B (fr)
AU (1) AU2016316811B2 (fr)
CA (1) CA2997511C (fr)
ES (1) ES2860803T3 (fr)
MX (1) MX394834B (fr)
NZ (1) NZ740555A (fr)
PH (1) PH12018500468A1 (fr)
RU (1) RU2748643C2 (fr)
UA (1) UA126059C2 (fr)
WO (1) WO2017037280A1 (fr)
ZA (1) ZA201801394B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3092935A1 (fr) 2018-03-06 2019-09-12 Precigen, Inc. Vaccins contre l'hepatite b et utilisations de ces derniers
WO2022207645A1 (fr) 2021-03-30 2022-10-06 Viravaxx AG Vaccin sous-unitaire contre le sars-cov-2
CN118019754A (zh) 2021-09-23 2024-05-10 维拉瓦克斯股份公司 诱导pres特异性中和抗体的hbv疫苗

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331443C (fr) 1987-05-29 1994-08-16 Charlotte A. Kensil Adjuvant a saponine
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
BR9811262A (pt) 1997-04-01 2000-10-17 Ribi Immunochem Research Inc Composições auxiliares imunológicas aquosas de lipìdio de monofosforila a.
WO2009092612A1 (fr) * 2008-01-25 2009-07-30 Universitätsklinikum Heidelberg Peptides issus de pres modifiés hydrophobes du virus de l'hépatite b (vhb) et leur utilisation en tant que véhicules pour l'administration spécifique de composés au foie
AU2012266246B2 (en) * 2011-06-09 2017-05-11 Worg Pharmaceuticals (Zhejiang) Co., Ltd. Peptide carrier fusion proteins as allergy vaccines

Also Published As

Publication number Publication date
US20180244726A1 (en) 2018-08-30
MX394834B (es) 2025-03-24
MX2018002616A (es) 2018-11-09
RU2018112060A3 (fr) 2020-01-29
CA2997511C (fr) 2023-10-17
EP3138579A1 (fr) 2017-03-08
JP6830955B2 (ja) 2021-02-17
JP2018531911A (ja) 2018-11-01
RU2018112060A (ru) 2019-10-07
EP3344292B1 (fr) 2020-12-30
HK1257937A1 (en) 2019-11-01
RU2748643C2 (ru) 2021-05-28
CN108472356A (zh) 2018-08-31
EP3344292A1 (fr) 2018-07-11
PH12018500468A1 (en) 2018-09-10
ES2860803T3 (es) 2021-10-05
US20220048955A1 (en) 2022-02-17
CA2997511A1 (fr) 2017-03-09
NZ740555A (en) 2025-05-02
KR20180039739A (ko) 2018-04-18
AU2016316811A1 (en) 2018-03-22
UA126059C2 (uk) 2022-08-10
WO2017037280A1 (fr) 2017-03-09
AU2016316811B2 (en) 2022-09-22
CN108472356B (zh) 2022-04-12

Similar Documents

Publication Publication Date Title
IL254965B (en) fusion proteins
GB201509413D0 (en) Fusion protein
ZA201701810B (en) Sirp-alpha immunoglobulin fusion proteins
ZA201704231B (en) Chimeric protein
GB201502305D0 (en) Protein
GB201502306D0 (en) Protein
IL246355B (en) p97–ids fused proteins
GB201504691D0 (en) Fusion protein
GB201515745D0 (en) Proteins
GB201511787D0 (en) Proteins
ZA202003845B (en) Fusion proteins
GB201506223D0 (en) Chimeric protein
IL247321A0 (en) uti chimeric proteins
GB201513033D0 (en) Proteins
ZA201801394B (en) Fusion protein
SG11201606501PA (en) Nanobody-fluorescent protein fusion
EP3649159C0 (fr) Protéine de fusion
GB201602850D0 (en) Fusion proteins
GB201712792D0 (en) Fusion protein
IL244857A0 (en) A fusion protein of acetylcholinesterase and the fc region
GB201522610D0 (en) Protein
GB201617799D0 (en) Fusion polypeptide
GB201503789D0 (en) Fusion polypeptide
GB201515744D0 (en) Proteins
GB201503778D0 (en) Proteins